FDA Approvals - FDA Accepts For Review Complete Response To Approvable Letter For
FDA Accepts For Review Complete Response To Approvable Letter For Entereg (Alvimopan) For POI (Medical News Today)
GlaxoSmithKline and Adolor Corporation announced that the US Food and Drug Administration (FDA) has accepted as complete, Adolor's response to the November 2006 New Drug Application (NDA) approvable letter for Entereg (alvimopan) for the management of postoperative ileus (POI). [click link for full article]
Friday's Health Winners & Losers (TheStreet.com)
Novartis rises on a European drug approval.